March 22, 2022
Opioid/Substance Use Disorders
  • Allergan and Teva Pharmaceutical reached a $107 million settlement with the state of Rhode Island over their alleged roles in fomenting the U.S. opioid crisis. Under the deal, Teva will pay $21.5 million over 13 years and supply the state with two medicines to combat opioid use disorder – Narcan and buprenorphine – valued at $78.5 million, based on wholesale prices. Allergan will pay $8 million over six years. (Articles here, here, and here)